Nicotinyl methylamide
| Names | |
|---|---|
| Preferred IUPAC name
N-Methylpyridine-3-carboxamide | |
| Other names
N-Methylnicotinamide; N-Methylniacinamide
| |
| Identifiers | |
CAS Number
|
|
3D model (JSmol)
|
|
| Abbreviations | NAN |
| ChEBI | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.003.679 |
| EC Number |
|
| MeSH | C008472 |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
InChI
| |
SMILES
| |
| Properties | |
Chemical formula
|
C7H8N2O |
| Molar mass | 136.154 g·mol−1 |
| Pharmacology | |
| A05AB01 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
Nicotinyl methylamide is an experimental drug with no approved indication.[1] It is also a metabolite of nicotinamide (vitamin B3) and is found in urine.[2]
See also
References
- ^ "N-methylnicotinamide". DrugBank.
- ^ "Nicotinyl methylamide". Inxight Drugs. National Center for Advancing Translational Sciences.